1. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017; 15:276–283.
Article
2. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf. 2003; 1:107–126.
Article
3. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011; 52:1930–1937.
Article
4. Wojtowicz JC, Butovich IA, McCulley JP. Historical brief on composition of human meibum lipids. Ocul Surf. 2009; 7:145–153.
Article
5. Kim EC. Diagnosis and treatment of dry eye syndrome. J Korean Med Assoc. 2018; 61:352–364.
Article
6. Eom Y, Lee JS, Kang SY, et al. Correlation between quantitative measurements of tear film lipid layer thickness and meibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls. Am J Ophthalmol. 2013; 155:1104–1110.
Article
7. Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea. 2013; 32:1549–1553.
Article
8. Kojima T, Dogru M, Matsumoto Y, et al. Tear film and ocular surface abnormalities after eyelid tattooing. Ophthalmic Plast Reconstr Surg. 2005; 21:69–71.
Article
9. Lee YB, Kim JJ, Hyon JY, et al. Eyelid tattooing induces meibomian gland loss and tear film instability. Cornea. 2015; 34:750–755.
Article
10. Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017; 15:511–538.
Article
11. Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011; 52:2006–2049.
Article
12. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003; 22:640–650.
Article
13. Arita R, Itoh K, Maeda S, et al. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009; 116:2058–2063.e1.
Article
14. Kim HM, Eom Y, Song JS. The relationship between morphology and function of the meibomian glands. Eye Contact Lens. 2018; 44:1–5.
Article
15. Takahashi Y, Watanabe A, Matsuda H, et al. Anatomy of secretory glands in the eyelid and conjunctiva: a photographic review. Ophthalmic Plast Reconstr Surg. 2013; 29:215–219.
16. Shams PN, Ortiz-Pérez S, Joshi N. Clinical anatomy of the periocular region. Facial Plast Surg. 2013; 29:255–263.
Article
17. Morrison C, Zuckerman S. My tattoos caused my dry eye? A new way to look at diagnosis and treatment for patients with tattoo eyeliner. Can J Optom. 2016; 78:6–15.
18. Goldman A, Wollina U. Severe unexpected adverse effects after permanent eye makeup and their management by Q-switched Nd:YAG laser. Clin Interv Aging. 2014; 9:1305–1309.
19. Liao JC, Proia AD, Ely PH, Woodward JA. Late-onset melanopenic hypomelanosis as a complication of cosmetic eyeliner tattoo. J Am Acad Dermatol. 2013; 69:e144–e146.
Article
20. Wolfley DE, Flynn KJ, Cartwright J, Tschen JA. Eyelid pigment implantation: early and late histopathology. Plast Reconstr Surg. 1988; 82:770–774.
21. Tse DT, Folberg R, Moore K. Clinicopathologic correlate of a fresh eyelid pigment implantation. Arch Ophthalmol. 1985; 103:1515–1517.
Article
22. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye (Lond). 1991; 5(Pt 4):395–411.
Article